Burden of Pneumococcal Disease in Young Children Due to Serotypes Contained in Different Pneumococcal Conjugate Vaccines in Eight Asian Countries and Territories
This study demonstrates the remaining and incremental burden of PD from PCV10 to PCV20 serotypes in young children in selected Asian regions. Extending NIP access to higher-valency PCVs with broader serotype coverage and improving vaccine uptake will help prevent morbidity and deaths and save healthcare costs.
Authors
- Winniefer Nua
- Ritika Rampal (ORCID: https://orcid.org/0000-0002-0642-3528)
- Shih‐Kai Hung (ORCID: https://orcid.org/0000-0002-4945-528X)
- Ricardo Avila
- Bulent Taysi (ORCID: https://orcid.org/0009-0003-2318-7293)
- Liping Huang (ORCID: https://orcid.org/0000-0003-1623-3397)
- Derek Daigle (ORCID: https://orcid.org/0009-0007-4350-6967)
- Xiuyan Li (ORCID: https://orcid.org/0000-0002-1643-8459)
- Namrata Kulkarni (ORCID: https://orcid.org/0000-0001-8730-6499)
- E Cheong
- Janaina Aparecida Medeiros Leung
- Ng Eugenia
- Kornvipa Choowanich
Institutions
- Pfizer (United States) (US)
- Pfizer (China) (CN)
- Pfizer (India) (IN)
Publication Details
- Journal
- Vaccines
- Published
- 2024-10-19
- DOI
- https://doi.org/10.3390/vaccines12101197
- Citations
- 3
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 1.16
Funders
- Pfizer